{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:44:11Z","timestamp":1760985851695,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001655","name":"DAAD","doi-asserted-by":"crossref","award":["57421248"],"award-info":[{"award-number":["57421248"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Spanish Ministry of Health\u2014Instituto Carlos III","award":["CP16\/00041"],"award-info":[{"award-number":["CP16\/00041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12035-019-01837-w","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T10:09:45Z","timestamp":1576577385000},"page":"1863-1874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-681X","authenticated-orcid":false,"given":"Matthias","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niccolo","family":"Candelise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Kanata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franc","family":"Llorens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Th\u00fcne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Villar-Piqu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana Margarida","family":"da Silva Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Dafou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Sklaviadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4611-8963","authenticated-orcid":false,"given":"Dietmar","family":"Appelhans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"issue":"6","key":"1837_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.brainresbull.2008.09.012","volume":"77","author":"K Schneider","year":"2008","unstructured":"Schneider K, Fangerau H, Michaelsen B, Raab WH (2008) The early history of the transmissible spongiform encephalopathies exemplified by scrapie. Brain Res Bull 77(6):343\u2013355","journal-title":"Brain Res Bull"},{"issue":"1","key":"1837_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/ajmg.b.32505","volume":"174","author":"LT Takada","year":"2017","unstructured":"Takada LT, Kim MO, Cleveland RW, Wong K, Forner SA, Gala II, Fong JC, Geschwind MD (2017) Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature. Am J Med Genet B Neuropsychiatr Genet 174(1):36\u201369","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"1837_CR3","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2016.5.FOCUS15126","volume":"41","author":"DJ Bonda","year":"2016","unstructured":"Bonda DJ, Manjila S, Mehndiratta P, Khan F, Miller BR, Onwuzulike K, Puoti G, Cohen ML et al (2016) Human prion diseases: surgical lessons learned from iatrogenic prion transmission. Neurosurg Focus 41(1):E10","journal-title":"Neurosurg Focus"},{"issue":"1","key":"1837_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0272-2712(02)00065-3","volume":"23","author":"P Gambetti","year":"2003","unstructured":"Gambetti P, Parchi P, Chen SG (2003) Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia. Clin Lab Med 23(1):43\u201364","journal-title":"Clin Lab Med"},{"key":"1837_CR5","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363\u201313383","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1837_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T et al (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17(2):175\u2013178","journal-title":"Nat Med"},{"issue":"2","key":"1837_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.23589","volume":"72","author":"LI McGuire","year":"2012","unstructured":"McGuire LI, Peden AH, Orr\u00fa CD, Wilham JM, Appleford NE, Mallinson G, Andrews M, Head MW et al (2012) Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 72(2):278\u2013285","journal-title":"Ann Neurol"},{"issue":"1","key":"1837_CR8","doi-asserted-by":"publisher","first-page":"e54915","DOI":"10.1371\/journal.pone.0054915","volume":"8","author":"K Sano","year":"2013","unstructured":"Sano K, Satoh K, Atarashi R, Takashima H, Iwasaki Y, Yoshida M, Sanjo N, Murai H et al (2013) Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One 8(1):e54915","journal-title":"PLoS One"},{"issue":"3","key":"1837_CR9","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","volume":"53","author":"M Cramm","year":"2016","unstructured":"Cramm M, Schmitz M, Karch A, Mitrova E, Kuhn F, Schroeder B, Raeber A, Varges D et al (2016) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol 53(3):1896\u20131904","journal-title":"Mol Neurobiol"},{"issue":"11","key":"1837_CR10","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/nprot.2016.120","volume":"11","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Cramm M, Llorens F, M\u00fcller-Cramm D, Collins S, Atarashi R, Satoh K, Orr\u00fa CD et al (2016) The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc 11(11):2233\u20132242","journal-title":"Nat Protoc"},{"key":"1837_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-1-4939-7816-8_16","volume":"1779","author":"M Schmitz","year":"2018","unstructured":"Schmitz M, Candelise N, Llorens F, Zerr I (2018) Amplification and detection of minuscule amounts of misfolded prion protein by using the real-time quaking-induced conversion. Methods Mol Biol 1779:257\u2013263","journal-title":"Methods Mol Biol"},{"key":"1837_CR12","doi-asserted-by":"publisher","first-page":"28711","DOI":"10.1038\/srep28711","volume":"6","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Cramm M, Llorens F, Candelise N, M\u00fcller-Cramm D, Varges D, Schulz-Schaeffer WJ, Zafar S et al (2016) Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie. Sci Rep 6:28711","journal-title":"Sci Rep"},{"issue":"10","key":"1837_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/14737159.2017.1368389","volume":"17","author":"N Candelise","year":"2017","unstructured":"Candelise N, Schmitz M, Da Silva Correia SM, Arora AS, Villar-Piqu\u00e9 A, Zafar S, Llorens F, Cramm M et al (2017) Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies. Expert Rev Mol Diagn 17(10):897\u2013904","journal-title":"Expert Rev Mol Diagn"},{"issue":"Pt 10","key":"1837_CR14","first-page":"26592668","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132(Pt 10):26592668","journal-title":"Brain"},{"issue":"1","key":"1837_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/1871526510909010092","volume":"9","author":"I Zerr","year":"2009","unstructured":"Zerr I (2009) Therapeutic trials in human transmissible spongiform encephalo-pathies: recent advances and problems to address. Infect Disord Drug Targets 9(1):92\u201399","journal-title":"Infect Disord Drug Targets"},{"issue":"5","key":"1837_CR16","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1021\/bm100101s","volume":"11","author":"M Fischer","year":"2010","unstructured":"Fischer M, Appelhans D, Klajnert B, Bryszewska M, Voit B, Rogers M (2010) The influence of surface functionality of poly(propylene imine) dendrimers on aggregation and propagation of the scrapie prion protein. Biomacromolecules 11(5):1314\u20131325","journal-title":"Biomacromolecules"},{"issue":"6","key":"1837_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/adhm.201200151","volume":"1","author":"JM McCarthy","year":"2012","unstructured":"McCarthy JM, Rasines B, Appelhans D, Rogers M (2012) Differentiating prion strains using dendrimers. Adv Healthcare Mater 1(6):768\u2013772","journal-title":"Adv Healthcare Mater"},{"issue":"1","key":"1837_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1021\/bm301165u","volume":"14","author":"JM McCarthy","year":"2013","unstructured":"McCarthy JM, Rasines B, Filippini D, Komber H, Maly M, Cernescu M, Brutschy B, Appelhans D et al (2013) Influence of surface groups on poly(propylene imine) dendrimers anti-prion activity. Biomacromolecules 14(1):27\u201337","journal-title":"Biomacromolecules"},{"issue":"1","key":"1837_CR19","doi-asserted-by":"publisher","first-page":"e55282","DOI":"10.1371\/journal.pone.0055282","volume":"8","author":"JM McCarthy","year":"2013","unstructured":"McCarthy JM, Franke M, Resenberger UK, Waldron S, Simpson JC, Tatzelt J, Appelhans D, Rogers M (2013) Anti-prion drug mPPIg5 inhibits PrPC conversion to PrPSc. PLoS One 8(1):e55282","journal-title":"PLoS One"},{"issue":"3","key":"1837_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4161\/pri.24431","volume":"7","author":"JM McCarthy","year":"2013","unstructured":"McCarthy JM, Appelhans D, Rogers M (2013) Nanomedicine for prion disease treatment: new insights into the role of dendrimers. Prion 7(3):198\u2013202","journal-title":"Prion"},{"key":"1837_CR21","doi-asserted-by":"crossref","unstructured":"Appelhans D, Cladera J, Rogers M, Voit B (2015) Dendritic glyco architectures - from H-bond-driven molecular interactions to their potential use in brain disease therapy. In: Becer CR, Hartmann L (eds) Glycopolymer Code: Synthesis of Glycopolymers and Their Applications, vol Chapter 5. Royal Society of Chemistry, pp. 149\u2013177","DOI":"10.1039\/9781782622666-00149"},{"issue":"3","key":"1837_CR22","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s12274-017-1734-9","volume":"11","author":"A Janaszewska","year":"2018","unstructured":"Janaszewska A, Klajnert-Maculewicz B, Marcinkowska M, Duchnowicz P, Appelhans D, Grasso G, Deriu MA, Danani A et al (2018) Multivalent interacting glycodendrimer to prevent amyloid-peptide fibril formation induced by Cu(II): a multidisciplinary approach. Nano Res 11(3):1204\u20131226","journal-title":"Nano Res"},{"key":"1837_CR23","doi-asserted-by":"crossref","unstructured":"Aso E, Marinsson I, Appelhans D, Benseny-Cases N, Effenberg C, Cladera J, Gouras G, Ferrer I, Klementieva O (2019) Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection. Nanomedicine: NBM 17:198-209","DOI":"10.1016\/j.nano.2019.01.010"},{"issue":"23","key":"1837_CR24","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.1002\/chem.200800342","volume":"14","author":"B Klajnert","year":"2008","unstructured":"Klajnert B, Appelhans D, Komber H, Morgner N, Schwarz S, Richter S, Brutschy B, Ionov M et al (2008) The influence of densely organized maltose shells on the biological properties of poly(propylene imine) dendrimers: New effects dependent on Hydrogen bonding. Chemistry 14(23):7030\u20137041","journal-title":"Chemistry"},{"issue":"11","key":"1837_CR25","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1021\/bm2008636","volume":"12","author":"O Klementieva","year":"2011","unstructured":"Klementieva O, Benseny-Cases N, Gella A, Appelhans D, Voit B, Cladera J (2011) Dense shell glycodendrimers as potential non-toxic anti-amyloidogenic agents in Alzheimer\u2019s Disease. Amyloid-dendrimer aggregates morphology and cell toxicity. Biomacromolecules 12(11):3903\u20133909","journal-title":"Biomacromolecules"},{"issue":"2","key":"1837_CR26","first-page":"261","volume":"99","author":"A Janaszewska","year":"2012","unstructured":"Janaszewska A, Ziemba B, Ciepluch K, Appelhans D, Voit B, Klajnert B, Bryszewska M (2012) The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluoroscein-proofs of crossing blood-brain-barrier. J Biomed Mater Res A 99(2):261\u2013268","journal-title":"J Biomed Mater Res A"},{"issue":"2","key":"1837_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jbm.a.33196","volume":"99","author":"B Ziemba","year":"2011","unstructured":"Ziemba B, Janaszewska A, Ciepluch K, Krotewicz M, Fogel WA, Appelhans D, Voit B, Bryszewska M et al (2011) In vivo toxicity of poly(propyleneimine) dendrimers. J Biomed Mater Res A 99(2):261\u2013268","journal-title":"J Biomed Mater Res A"},{"key":"1837_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1039\/C1NJ20489K","volume":"36","author":"A Janaszewska","year":"2012","unstructured":"Janaszewska A, M\u0105czy\u0144ska K, Matuszko G, Appelhans D, Voit BKB, Bryszewska M (2012) Cytotoxicity of PAMAM, PPI and maltose modified PPI dendrimers in Chinese hamster ovary (CHO) and human ovarian carcinoma (SKOV3) cells. New J Chem 36:428\u2013437","journal-title":"New J Chem"},{"issue":"11","key":"1837_CR29","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1002\/jbm.a.34222","volume":"A100","author":"B Ziemba","year":"2012","unstructured":"Ziemba B, Halets I, Shcharbin D, Appelhans D, Voit B, Pieszynski I, Bryszewska M, Klajnert B (2012) Influence of fourth generation poly(propyleneimine) dendrimers on blood cells. J Biomed Mater Res A100(11):2870\u20132880","journal-title":"J Biomed Mater Res"},{"key":"1837_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1039\/C1NJ20444K","volume":"36","author":"A Janaszewska","year":"2012","unstructured":"Janaszewska A, Ziemba B, Ciepluch K, Appelhans D, Voit B, Klajnert B, Bryszewska M (2012) The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluoroscein-proofs of crossing blood-brain-barrier. New J Chem 36:350\u2013353","journal-title":"New J Chem"},{"issue":"12","key":"1837_CR31","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1039\/C4CS00339J","volume":"44","author":"D Appelhans","year":"2015","unstructured":"Appelhans D, Klajnert-Maculewicz B, Janaszewska A, Lazniewska J, Voit B (2015) Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications. Chem Soc Rev 44(12):3968\u20133996","journal-title":"Chem Soc Rev"},{"key":"1837_CR32","volume-title":"Poly (Propylene Imine) Dendrimers. Polymer Data Handbook","author":"DA Tomalia","year":"2009","unstructured":"Tomalia DA, Rookmaker M (2009) Poly (Propylene Imine) Dendrimers. Polymer Data Handbook. Oxford University Press, New York"},{"issue":"1","key":"1837_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1128\/JVI.74.1.320-325.2000","volume":"74","author":"N Nishida","year":"2000","unstructured":"Nishida N, Harris DA, Vilette D, Laude H, Frobert Y, Grassi J, Casanova D, Milhavet O et al (2000) Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 74(1):320\u2013325","journal-title":"J Virol"},{"issue":"5","key":"1837_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1468-1331.2008.02108.x","volume":"15","author":"I Bone","year":"2008","unstructured":"Bone I, Belton L, Walker AS, Darbyshire J (2008) Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK. Eur J Neurol 15(5):458\u2013464","journal-title":"Eur J Neurol"},{"issue":"3","key":"1837_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001888","volume":"3","author":"A De Luigi","year":"2008","unstructured":"De Luigi A, Colombo L, Diomede L, Capobianco R, Mangieri M, Miccolo C, Limido L, Forloni G et al (2008) The efficacy of tetracyclines in peripheral and intracerebral prion infection. PLoS One 3(3):e1888","journal-title":"PLoS One"},{"issue":"5","key":"1837_CR36","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1440-1789.2009.01058.x","volume":"29","author":"Y Tsuboi","year":"2009","unstructured":"Tsuboi Y, Doh-Ura K, Yamada T (2009) Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases. Neuropathology 29(5):632\u2013636","journal-title":"Neuropathology"},{"issue":"4","key":"1837_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.10336","volume":"52","author":"SJ Collins","year":"2002","unstructured":"Collins SJ, Lewis V, Brazier M, Hill AF, Fletcher A, Masters CL (2002) Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neuol 52(4):503\u2013506","journal-title":"Ann Neuol"},{"issue":"23","key":"1837_CR38","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/WNL.0b013e3182a9f3b4","volume":"81","author":"MD Geschwind","year":"2013","unstructured":"Geschwind MD, Kuo AL, Wong KS, Haman A, Devereux G, Raudabaugh BJ, Johnson DY, Torres-Chae CC et al (2013) Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease. Neurology 81(23):2015\u20132023","journal-title":"Neurology"},{"issue":"2","key":"1837_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3892\/ijmm.2014.1814","volume":"34","author":"JH Moon","year":"2014","unstructured":"Moon JH, Lee JH, Park JY, Kim SW, Lee YJ, Kang SJ, Seol JW, Ahn DC et al (2014) Caffeine prevents human prion protein-mediated neurotoxicity through the induction of autophagy. Int J Mol Med 34(2):553\u2013558","journal-title":"Int J Mol Med"},{"issue":"2","key":"1837_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","volume":"13","author":"S Ha\u00efk","year":"2014","unstructured":"Ha\u00efk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V et al (2014) Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 13(2):150\u2013158","journal-title":"Lancet Neurol"},{"issue":"1","key":"1837_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mnfr.201400290","volume":"59","author":"VL Ngoungoure","year":"2015","unstructured":"Ngoungoure VL, Schluesener J, Moundipa PF, Schluesener H (2015) Natural polyphenols binding to amyloid: a broad class of compounds to treat different human amyloid diseases. Mol Nutr Food Res 59(1):8\u201320","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"1837_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/jnnp-2016-313541","volume":"88","author":"D Varges","year":"2017","unstructured":"Varges D, Manthey H, Heinemann U, Ponto C, Schmitz M, Schulz-Schaeffer WJ, Krasnianski A, Breithaupt M et al (2017) Doxycycline in early CJD: a double-blinded randomised phase II and observational study. J Neurol Neurosurg Psychiatry 88(2):119\u2013125","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01837-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01837-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01837-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T01:09:24Z","timestamp":1608080964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01837-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,17]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1837"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01837-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2019,12,17]]},"assertion":[{"value":"22 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have not competing interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}